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ABSTRACT  
The deleterious dietetic habit and regimes leads to digestive disturbances; which 
further leads to disturbances in bowel habits. Among these disorders Parikartika 
is one in which patient experiences unendurable pain during and after 
defecation, burning sensation etc. due to agony of pain patient avoids to 
defecate, hence constipated. Fissure-in-ano afflicts both sexes but males suffer 
posteriorly while females suffer anteriorly. Until now some drugs were tried as 
an external application to relieve the pain and healing of the ulcer. This study 
was conducted to find the efficacy Ayurvedic drug over the standard modern 
drug. The patients attending OPD & IPD of Jammu Institute of Ayurveda and 
Research College and Hospital, were the source for study. 30 patients were 
clinically diagnosed as Parikartika were selected randomly and divided into two 
groups. Group A: Comprised of 15 patients and they were administered 
internally with Vedanasthapana Kshaya 1 Pala b.d, Erandbhrshta Haritaki at bed 
time, local application of Karpoora Ghrita 4 times a day and sitz bath with 
Panchvalakala Kwatha three times a day and before and after the defecation. 
Group B: Consisted of 15 patients and were administered internally with 
Ofloxacin, Ornidazole (200+500mg) combination b.d, Diclofenac sodium (50mg) 
b.d, Sodium picosulfate 1 tsf bedtime, sitz bath with lukewarm water. Duration of 
treatment was two months. The patients were followed up fortnightly for a 
period of two months. Both the groups had shown statistically significant 
changes. The therapy provided significant relief and healing of ulcer in this 
study. Therefore prescription from Bhaishjya Ratnawali of Karpoora Ghrita and 
Pachvalkala Kwatha along with Acharya Charak prescription of Vedanasthapana 
Kshaya and Anubhutta Yoga of Erandbhrshta Haritaki showed good and 
alternative result for the modern standard prescription. 
INTRODUCTION
 Fissure-in-ano is a very common and painful 
condition. Fissures occur most commonly in the midline 
posteriorly, the least protected part of the anal canal. In 
males fissures usually occur in the midline posteriorly 
(90%) and much less commonly anteriorly (10%). In 
females fissures on the midline posteriorly commoner 
than anteriorly (60:40).1 the numerous diseases having 
pain as a primary character, Parikartika is one among 
them. Pain is highlighted symptom characterised by 
sufferer. Parikartika is a longitudinal tear in the long axis 
of lower anal canal which can be observed anteriorly or 
posteriorly, very painful and difficult to heal2. Our 
ancient epics had already mentioned the condition 
3000BC back. Acharya Sushruta and Charaka had 
mentioned this as a complication of other diseases and 
Karmas3,4. Later on it developed as an independent 
disease due to fanciful diet and unhealthy food habits 
results in the vitiation of Doshas, which in turn cause 
disturbances in digestive tract further biological clock is 
altered leading to irregularity in the excretory functions 
like defecation and micturation. Because of altered food 
habits constipation occurs, which cause tear in the anal 
canal. Parikartika is very much similar to the fissure-in-
ano as mentioned in the modern texts. The pain is an 
important subjective sensation experienced by the 
patient in various pathological manifestations. A 
sensation of pain, which is the result of stimulant with 
sufficient threshold, primarily acts as an important 
protective mechanism i.e. a warning signal, but later 
become pathological. 
 In this present study the patients suffering from 
fissure-in-ano are subjected to Karpoora Ghrita, 
Vedanasthapana Kshaya, Panchvalakala Kwatha sitz bath 
and Erandbhrshta Haritaki for assessment of their 
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analgesic effects and healing the wound of fissure-in-ano. 
The result is compared with modern established 
Diclofenac sodium, Ofloxacin, Ornidazole, Sodium 
picosulfate and warm water sitz bath. An effort has made 
in this study to find effective Vedanasthapana Upaya for 
patients who are suffering from fissure-in-ano.  
 For this present study 30 patients attending to 
OPD and IPD of Shalya Tantra in Jammu Institute of 
Ayurveda and Research College and Hospital, are 
selected randomly and divided in two groups and 
subjected to clinical trial. Group- A Is administered with 
Vedanasthapana Kshaya, Karpoora Ghrita, Panchvalkala 
Kwath sitz bath and Erandbhrshta Haritaki. Group- B Is 
administered with Diclofenac Sodium, Ofloxacin 
Ornidazole and Sodium picosulfate and luke warm water 
sitz bath. The schedule for treatment is for seven days 
and follow up fortnightly for two month. 
MATERIALS AND METHODS   
Source of data: Inpatients and Outpatients with 
complaint of Parikartika from J.I.A.R Hospital Jammu, 
Nardni. 
Method of collection of data: 30 randomly selected 
Patients with complaints of Parikartika. Patients will be 
grouped into two groups of 15 patients each and the 
results will be assessed on comparative studies of 
features of BT and AT proforma, designed especially for 
this study. 
In the group A: It consists of 15 patients. Internal 
medication with Vedanasthapana Kshaya 1 pala b.d and 
Erandbhrshta Haritaki 1tsf at bed time, locally Karpoora 
Ghrita in form of Pichu after anal dilatation, sitz bath with 
Panchvalkala Kwatha 8 hourly and before and after 
defecation.  
In group B: Internal medication with Ofloxacin and 
ornidazole (200+500mg) 1 tab b.d and diclofenac sodium 
(50mg) 1 tab b.d and sodium picosulfate syp 5ml bed 
time and sitz bath with lukewarm water. 
 Selected patients were asked to visit on 7th day, 
22th day, 37th day, 52th day, and 60th day and were 
examined for the findings and assessed according to the 
assessment criteria mentioned in the proforma and data 
were collected.  
Intervention: Patient will be admitted in the hospital 
after explaining the treatment procedure. The patient 
will be kept NBM night before the treatment and enema 
will be given before the procedure. After making 
lithotomy position, the Ghrita is applied locally in 
patients of Group A. But no medicine is applied locally in 
Group B. After the procedure, medicines of Group A and 
Group B will be given orally separately.  
Duration of treatment – 2 months 
a) Observation period: The patients are observed up to 
2 months. Assessment criteria will be recorded at 
intervals of seven and fifteen days during observation 
period. 
b) Inclusion criteria 
Patient willing to undergo trial 
Patients who are clinically diagnosed as Parikartika 
Patients of both sexes 
Age between 20 years-60 years. 
c) Exclusion criteria 
Patients who are not willing to undergo the trial 
Patients having any anorectal disease other than Fissure 
Patients with uncontrolled systemic disease like D.M., 
Hepatitis, T.B., HIV 
Pregnant women 
Assessment criteria: The patient’s response is assessed 
on the basis of subjective and objective criteria. 
Subjective criteria- Nature of pain: 
As the sufferer himself expressed the pain in his own 
terms, so this was graded, starting from mild to 
unbearable. The grading given is  
1. Grading for Nature of Pain 
Symptom  Grading 
Absent - 0 
Mild - 1 
Moderate - 2 
Severe - 3 
Unbearable - 4 
2. Grading for Pain Duration 
Symptom  Grading 
No Pain - 0 
30min - 1 
60min - 2 
12hours - 3 
24hours - 4 
>24hours  5 
3. Grading for constipation 
Symptom  Grading 
Absent - 0 
Mild - 1 
Moderate - 2 
Severe - 3 
4. Grading for Bleeding 
Symptom  Grading 
Absent - 0 
In streak - 1 
In drops - 2 
Profuse - 3 
5. Grading for Passing flatus 
Symptom  Grading 
Without effort - 0 
With effort - 1 
6. Grading for Diarrhea 
Symptom  Grading 
Absent - 0 
Present - 1 
7. Grading for itching 
Symptom Grading  
Absent - 0 
Complain when asked - 1 
Relieved with sitz bath - 2 
Often and discomfort - 3 
Severe and constant all 
day 
- 4 
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8. Grading for discharge 
Symptom  Grading 
Absent - 0 
Occasional - 1 
Often feeling wetness - 2 
Wetness but no soiling of clothes - 3 
Soiling of clothes - 4 
Objective criteria 
1.Grading for size of ulcer 
Symptom  Grading 
Absent - 0 
1-5mm - 1 
6-10mm - 2 
>10mm - 3 
2. Grading for Location of Ulcer 
Symptom  Grading 
Absent - 0 
Anterior - 1 
Posterior - 2 
3.Grading for sphincter tone 
Symptom  Grading 
Normal - 0 
Spasmodic - 1 
4.Grading for proctitis 
Symptom  Grading 
Absent - 0 
Present - 1 
5.Grading for Local Tenderness 
Symptom  Grading 
Absent - 0 
Pain on palpation - 1 
Tenderness on light pressure - 2 
Pain on touch - 3 
Does not allow to touch - 4 
RESULTS 
Statistical analysis: This was conducted on SPSS 
software, paired sample t-test were used to find out the 
significant level of these drugs. By comparing before and 
after statistics at 95% confidence level it showed that 
almost all pairs were statistical significant. 
Table 1: Showing effect of therapy on different signs & symptoms before and after treatment 
S.No Symptoms  Group Mean  S.D S.E Paired t-test 
BT AT B.T A.T B.T A.T df t-value p-value 
1. Pain  A 2.86 0.20 0.64 0.458 0.165 0.118 14 19.86 0.00 
B 3.06 0.4 0.704 0.507 0.182 0.131 14 16.73 0.00 
2. Duration of 
pain 
A 3.13 0.26 0.743 0.488 0.192 0.118 14 17.35 0.00 
B 3.06 0.4 0.799 0.507 0.206 0.131 14 11.48 0.00 
3. Constipatio
n 
A 1.53 0.006 0.990 0.258 0.256 0.067 14 6.20 0.00 
B 1.67 0.2 1.11 0.414 0.29 0.108 14 5.505 0.00 
4. Bleeding A 1.20 0 0.77 0 0.2 0 14 6.00 0.00 
B 1.80 0 0.67 0 0.175 0 14 10.31 0.00 
5. Flatus 
passes 
A 0.4 0 0.50 0 0.131 0 14 3.06 0.009 
B 0.33 0 0.48 0 0.126 0 14 2.65 0.019 
6. Diarrhea A 0 0 0 0 0 0 0 0 0 
B 0 0 0 0 0 0 0 0 0 
7. Itching A 0.33 0 0.488 0 0.126 0 14 2.65 0.019 
B 0.33 0 0.488 0 0.126 0 14 2.65 0.019 
8. Discharge A 3.53 0.33 0.516 0.488 0.133 0.126 14 14.38 0.00 
B 3.6 0.40 0.507 0.507 0.131 0.131 14 18.33 0.00 
INVESTIGATIONS
 The routine blood tests were advised to exclude 
the systemic diseases. In blood tests recommended tests 
are; Hb%, TLC, DLC, ESR and RBS. The normal urine 
routine test is sugar, albumin and microscopy5. 
DISSCUSSION  
Probable Mode of Action of all the Indigenous Drugs 
 On the basis of above description & clinical 
findings probable mode of action of drugs of Group A on 
Parikartika can be hypothetically postulated. Due to 
Kashaya Rasa6, the excessive reactionary inflammation is 
being checked in earlier phase (Pitta Kaphashamak), 
squeezes out toxins and necrotic tissue (Pidana) and thus 
checks excessive exudation and connective tissue 
response (Kleda Puya Sleshama Shoshana) and thus 
facilitate wound healing (Ropana). The drugs are having 
Guru7, Rooksha8 and SheetaGuna9 which also scrapes 
away the unhealthy tissues, dry up the discharge and 
ultimately helps in promotion of healing by nourishing 
the tissues.  
 Katu Rasa10 reduces the local discharge (Kleda 
Upshoshana), irritation (Kandu Prashamana), act as 
antimicrobial (Krimighana) and discourages excessive 
granulation tissue formation (Vranan Avasadhyati). 
Further all these actions are enhanced by Tikta Rasa. Due 
to Srotoshodhana property of Katu Rasa and Tikta Rasa 
channels get clear away (Srotamsi Vivrunoti), Ushna 
Virya11, Laghu12, Teekshana13 Sukshma14 Guna it 
penetrates in deep tissues and debride the wound.  
 Madhura Vipaka15 and Snigdha Guna16 further 
facilitate Vrana Shodhana, Ropana karma, which further 
helped in removal of any debris left (Madhur 
Sristhvinmutro)17, helps in growth of destroyed Vrana 
Adhisthana (Tatra Madhur Rasa Sarva Dhatu 
Vardhanam)18 promotes biosynthesis of mucopoly-
saccarides and collagen due to its (Jeevaniya, 
Bruhumaniya, Preernam)19 property and thus facilitate 
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Ropana by regeneration and organization of various 
tissue (Ksheenakshata Sandhankaro)20. Also Suksham and 
Guru Guna and Madhur Rasa promote the release of 
constipation, as it helps in deportation of constipation 
(Vidbandhbragnshothaa21 and Anulomana, Vibandha22). 
Madhur Vipaka, Guru Guna and Snigdha Guna reduces the 
pain and did not alleviate it any more. The combination 
of drugs did not alleviates the Pitta and Kapha with 
provoking Vata. 
CONCLUSION 
 Observation, analysis and results of the present 
study entitled–“ Collated Upshot of Indigenous Drugs in 
the Management of Parikartika w.s.r to Fissure-in-ano” 
can be concluded as follows: 
 Parikartika is very much similar to Fissure-in-
ano. Pain experienced by the patient is unbearable, 
cutting and burning in nature that can cause discomfort 
to the patient throughout the day. A suitable drug should 
be preferred which rather promotes healing of ulcer and 
relief from pain in very short time without producing 
side effects and improves general health of patients.  
 Karpoora Ghrita mentioned in Bhaishjya 
Ratnawali in the context of Sadhyovrana chapter is found 
efficacious in wound healing. The topical application of 
drug not only reduces pain, burning sensation and 
itching but also acts as debriding agent and paves way 
for smooth and uninterrupted healing of the ulcer. Oral 
intake of Vedanasthapana Kshaya also acts as sedative, 
analgesics and anti-inflammatory, which give relief from 
agonizing pain. The sitz bath of Panchvalkala Kwatha 
impoverished the bleeding, pain and edema which helps 
in gradual improvement in granulation tissue and 
enhances epithelization as it is having astringent 
property. 
 Besides the laxative property of Erandbhrshta 
Haritaki, it also acts as analgesic, anti-inflammatory, 
antifungal, antihemorrhagic and antiulcerative. This drug 
recede the ulcer by gradual improvement in granulation 
tissue. 
 Although ofloxacin + ornidazole has good effect 
over the infection in Fissure-in-ano by subsiding the 
growth of microbes but has many side effects like 
peripheral neuropathy, tendon damage, pseudo-
membranous colitis, rhabdomyolysis, Stevens-Johnson 
syndrome, hepatic failure, toxic epidermal necrolysis and 
clostridium difficile associated diarrhea, somnolence, 
headache, nausea, vomiting, dizziness, tremor, rigidity, 
poor coordination, seizures, vertigo, signs of sensory or 
mixed peripheral neuropathy, taste disturbances, 
abnormal LFTs, skin reactions. 
 Diclofenac sodium is good analgesic and anti 
inflammatory agent but frequent use of the drug for the 
reduction of unbearable cutting and agonizing pain of 
fissure can cause epigastric pain, nausea, rashes, gastric 
ulceration, increase risk of myocardial infarction, 
hepatotoxicity, rarely renal damage, bone marrow 
depression and risk of stroke. Sodium picosulfate is 
osmotic purgative but not as effective as Erandbhrshta 
Haritaki. 
 Sitz bath with lukewarm water only soothes 
from pain but did not promote healing, as the 
Panchvakala Kwatha did. Hence from the present clinical 
study, it can be speculated that Indigenous Drugs used in 
the management of Parikartika possess sufficient efficacy 
in Vedanasthapana, Vrana Shodana & Vrana Ropana 
without producing any adverse effects in the 
management of Parikartika. 
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